Cargando…
Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease
BACKGROUND: Given the implication of histone acetylation in memory processes, histone deacetylase inhibitors (HDACIs) have been postulated as potential modulators of cognitive impairment in Alzheimer’s disease (AD). However, dose-dependent side effects have been described in patients with the curren...
Autores principales: | Cuadrado-Tejedor, M., Garcia-Barroso, C., Sanzhez-Arias, J., Mederos, S., Rabal, O., Ugarte, A., Franco, R., Pascual-Lucas, M., Segura, V., Perea, G., Oyarzabal, J., Garcia-Osta, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599811/ https://www.ncbi.nlm.nih.gov/pubmed/26457123 http://dx.doi.org/10.1186/s13148-015-0142-9 |
Ejemplares similares
-
Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease
por: Cuadrado-Tejedor, Mar, et al.
Publicado: (2019) -
Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice
por: Pascual-Lucas, Maria, et al.
Publicado: (2014) -
Current Animal Models of Alzheimer’s Disease: Challenges in Translational Research
por: Cuadrado-Tejedor, Mar, et al.
Publicado: (2014) -
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
por: Peixoto, Christina Alves, et al.
Publicado: (2015) -
Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization
por: Rabal, Obdulia, et al.
Publicado: (2018)